Literature DB >> 8300225

Cellular and humoral immune responses to well-defined blood stage antigens (major merozoite surface antigen) of Plasmodium falciparum in adults from an Indian zone where malaria is endemic.

L Kabilan1, V P Sharma, P Kaur, S K Ghosh, R S Yadav, V S Chauhan.   

Abstract

Conserved and variant regions of two blood stage vaccine candidate antigens of Plasmodium falciparum, merozoite surface antigen (MSA-1) and ring-infected erythrocyte surface antigen (Pf155/RESA), have been shown to be immunogenic. However, the relative immunogenicity of these immunogens in different populations has not been studied. The conserved N-terminal region of MSA-1 was investigated for its immunogenicity by studying cellular (T cell) and humoral (B cell) immune responses in P. falciparum-primed individuals, living in malaria-hyperendemic areas (Orissa State, India), where malaria presents an alarming situation. MSA-1-derived synthetic peptides contained sequences that activated T cells to proliferate and release gamma interferon in vitro. There was considerable variation in the responses to different peptides. However, the highest responses (51% [18 of 35] by proliferation and 34% [12 of 35] by gamma interferon release) were obtained with a synthetic hybrid peptide containing sequences from conserved N- and C-terminal repeat regions of MSA-1 and Pf155/RESA, respectively. Antibody reactivities in an enzyme immunoassay of plasma samples from these donors to different peptides used for T-cell activation were heterogeneous. In general, there was poor correlation between DNA synthesis and either gamma interferon release or antibody responses in individual donors, underlining the importance of examining several parameters of T-cell activation to assess the total T-cell responsiveness of a study population to a given antigen. However, the results from our studies suggest that synthetic constructs containing sequences from the N- and C-terminal regions of MSA-1 and Pf155/RESA representing different erythrocytic stages of the P. falciparum parasite are more immunogenic in humans living in malaria-hyperendemic areas of India who have been primed by natural infection.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8300225      PMCID: PMC186158          DOI: 10.1128/iai.62.2.685-691.1994

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  47 in total

1.  Multiple cross-reactivities amongst antigens of Plasmodium falciparum impair the development of protective immunity against malaria.

Authors:  R F Anders
Journal:  Parasite Immunol       Date:  1986-11       Impact factor: 2.280

2.  Passive immunization of Aotus monkeys with human antibodies to the Plasmodium falciparum antigen Pf155/RESA.

Authors:  K Berzins; H Perlmann; B Wåhlin; H P Ekre; B Högh; E Petersen; B Wellde; M Schoenbechler; J Williams; J Chulay
Journal:  Infect Immun       Date:  1991-04       Impact factor: 3.441

3.  Number of cells from Plasmodium falciparum-immune donors that produce gamma interferon in vitro in response to Pf155/RESA, a malaria vaccine candidate antigen.

Authors:  L Kabilan; M Troye-Blomberg; G Andersson; E M Riley; H P Ekre; H C Whittle; P Perlmann
Journal:  Infect Immun       Date:  1990-09       Impact factor: 3.441

4.  Immune sera recognize on erythrocytes Plasmodium falciparum antigen composed of repeated amino acid sequences.

Authors:  R L Coppel; A F Cowman; R F Anders; A E Bianco; R B Saint; K R Lingelbach; D J Kemp; G V Brown
Journal:  Nature       Date:  1984 Aug 30-Sep 5       Impact factor: 49.962

5.  Monoclonal antibody two-site ELISA for human IFN-gamma. Adaptation for determinations in human serum or plasma.

Authors:  G Andersson; H P Ekre; G Alm; P Perlmann
Journal:  J Immunol Methods       Date:  1989-12-20       Impact factor: 2.303

6.  Regulation of the immune response in Plasmodium falciparum malaria: IV. T cell dependent production of immunoglobulin and anti-P. falciparum antibodies in vitro.

Authors:  L Kabilan; M Troye-Blomberg; M E Patarroyo; A Björkman; P Perlmann
Journal:  Clin Exp Immunol       Date:  1987-05       Impact factor: 4.330

7.  Cell-mediated immune responses to Plasmodium falciparum antigens in adult Gambians.

Authors:  E M Riley; S Jepsen; G Andersson; L N Otoo; B M Greenwood
Journal:  Clin Exp Immunol       Date:  1988-03       Impact factor: 4.330

8.  Community-based malaria control in India.

Authors:  V P Sharma
Journal:  Parasitol Today       Date:  1987-07

9.  Primary structure of the precursor to the three major surface antigens of Plasmodium falciparum merozoites.

Authors:  A A Holder; M J Lockyer; K G Odink; J S Sandhu; V Riveros-Moreno; S C Nicholls; Y Hillman; L S Davey; M L Tizard; R T Schwarz
Journal:  Nature       Date:  1985 Sep 19-25       Impact factor: 49.962

10.  Genetic control of the immune response in mice to a Plasmodium falciparum sporozoite vaccine. Widespread nonresponsiveness to single malaria T epitope in highly repetitive vaccine.

Authors:  M F Good; J A Berzofsky; W L Maloy; Y Hayashi; N Fujii; W T Hockmeyer; L H Miller
Journal:  J Exp Med       Date:  1986-08-01       Impact factor: 14.307

View more
  5 in total

1.  Possible relationship between Plasmodium falciparum ring-infected erythrocyte surface antigen (RESA) and host cell resistance to destruction by chemicals.

Authors:  Augustine U Orjih; Preethi T Cherian
Journal:  Parasitol Res       Date:  2013-09-05       Impact factor: 2.289

2.  Different regions of the malaria merozoite surface protein 1 of Plasmodium chabaudi elicit distinct T-cell and antibody isotype responses.

Authors:  S J Quin; J Langhorne
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

3.  Differential cellular recognition of antigens during acute Plasmodium falciparum and Plasmodium vivax malaria.

Authors:  Ervi Salwati; Gabriela Minigo; Tonia Woodberry; Kim A Piera; Harini D de Silva; Enny Kenangalem; Emiliana Tjitra; Ross L Coppel; Ric N Price; Nicholas M Anstey; Magdalena Plebanski
Journal:  J Infect Dis       Date:  2011-04-15       Impact factor: 5.226

4.  Analysis of immune responses against T- and B-cell epitopes from Plasmodium falciparum liver-stage antigen 1 in rodent malaria models and malaria-exposed human subjects in India.

Authors:  S K Joshi; A Bharadwaj; S Chatterjee; V S Chauhan
Journal:  Infect Immun       Date:  2000-01       Impact factor: 3.441

5.  Interferon-gamma responses to Plasmodium falciparum liver-stage antigen-1 and merozoite-surface protein-1 increase with age in children in a malaria holoendemic area of western Kenya.

Authors:  Kiprotich Chelimo; Peter O Sumba; James W Kazura; Ayub V Ofula; Chandy C John
Journal:  Malar J       Date:  2003-11-05       Impact factor: 2.979

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.